Health Condition 1: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders
Conditions
Interventions
Intervention1: DIALOG plus: technology assisted resource oriented approach which includes structured patient assessment of life domain satisfaction followed by four step solution-focused therapy appro
Sponsors
National Institute for Health Research
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of psychosis Aged over 18 years Capacity for informed consent Can speak and understand the local language Has a low quality of life scoring less than 5 on the MANSA for clinicians any professional background having regular contact with patients with psychosis
Exclusion criteria
Exclusion criteria: Dementia and or significant cognitive impairment and or severe learning disability Organic psychosis or drug induced psychosis if given as the primary diagnosis Unable to provide informed consent clinicians who do not have regular contact with patients with psychosis and do not speak the local language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective quality of life measured using the Manchester Short Assessment of Quality of Life called MANSATimepoint: 6 months 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospitalisation measured using the client Service resource inventory Symptoms measured using brief psychiatry rating scale at baseline 6 months and 12 months Negative symptoms measured using the scale for the assessment of Negative Symptoms at baseline 6 and 12 months Objective social situation measured using the Objective Social Outcomes Index SIX at baseline 6 and 12 months Therapeutic alliance measured using the Helping Alliance Questionnaire at baseline 6 and 12 months Health related quality of life measured using EQ5D 3L at baseline 6 and 12 months Service use measured using the Client Service Receipt Inventory at baseline 6 and 12 monthsTimepoint: 6 months 12 months | — |
Countries
India, Pakistan
Contacts
Public ContactPadmavati Ramachandran
Schizophrenia Research Foundation
Outcome results
None listed